ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Grants Fast Track Designation for Meniere's Disease Treatment
September 19, 2019Sound Pharmaceuticals announced the FDA's Division of Neurology Products has approved its request for Fast Track Designation (FTD) involving SPI-1005 in the treatment of Meniere's Disease (MD). -
Otonomy’s renaissance starts as Ménière’s disease drug clears trial
November 10, 2017Just weeks after a phase 3 setback caused it to slash staff and R&D programs, Otonomy has bounced back with a positive late-stage trial for its lead candidate Otividex in Ménière’s disease. -
Otonomy’s renaissance starts as Ménière’s disease drug clears trial
November 10, 2017Just weeks after a phase 3 setback caused it to slash staff and R&D programs, Otonomy has bounced back with a positive late-stage trial for its lead candidate Otividex in Ménière’s disease.
Pharma Sources Insight January 2025
